Efficacy and Safety of Radiotherapy Combined with Chemoimmunotherapy vs. Chemoimmunotherapy Alone as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma with Oligorecurrence

被引：0
|
作者：
Lv, X. [1 ]
Wang, Y. [1 ]
Ai, J. [1 ]
Wang, Q. [1 ]
Wang, J. [2 ]
机构：
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
[2] Hebei Med Univ, Hosp 4, Dept Radiat Oncol, Shijiazhuang, Hebei, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3089
引用
收藏
页码：E493 / E493
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of HAIC alone vs. HAIC combined with lenvatinib for treatment of advanced hepatocellular carcinoma
    Long, Fang
    Chen, Shali
    Li, Ruidong
    Lin, Yinsheng
    Han, Jian
    Guo, Jiandong
    Chen, Yongxin
    Li, Chengzhi
    Song, Peng
    MEDICAL ONCOLOGY, 2023, 40 (05)
  • [22] Efficacy and safety of HAIC alone vs. HAIC combined with lenvatinib for treatment of advanced hepatocellular carcinoma
    Fang Long
    Shali Chen
    Ruidong Li
    Yinsheng Lin
    Jian Han
    Jiandong Guo
    Yongxin Chen
    Chengzhi Li
    Peng Song
    Medical Oncology, 40
  • [23] Nimotuzumab combined with chemotherapy as first-line treatment for advanced lung squamous cell carcinoma
    Si, Xiaoyan
    Wu, Shafei
    Wang, Hanping
    Zhang, Xiaotong
    Wang, Mengzhao
    Zeng, Xuan
    Zhang, Li
    THORACIC CANCER, 2018, 9 (08) : 1056 - 1061
  • [24] COST-EFFECTIVENESS OF FIRST-LINE NIVOLUMAB COMBINATION THERAPY VS CHEMOTHERAPY ALONE FOR ADVANCED OR METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA
    Ben-Umeh, K.
    Okoye, G.
    Malone, D. C.
    King, J.
    VALUE IN HEALTH, 2023, 26 (06) : S87 - S88
  • [25] A propensity score-matched analysis of neoadjuvant chemoimmunotherapy versus surgery alone for locally advanced esophageal squamous cell carcinoma
    Wang, Kexi
    Liang, Yicheng
    Huang, Jing
    Xie, Xuan
    Wu, Duoguang
    Chen, Baishen
    Wang, Kefeng
    Shen, Zhuojian
    Li, Yuquan
    Wang, Wenjian
    Hu, Xueting
    Wang, Minghui
    JOURNAL OF SURGICAL ONCOLOGY, 2023, 128 (02) : 207 - 217
  • [26] First-Line Chemotherapy vs Chemoimmunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung, a Retrospective Study
    Meng, L.
    Laber, D.
    Cao, B.
    Shafique, M.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S531 - S532
  • [27] Comparison of efficacy and safety of first-line systemic therapy combined with or without radiotherapy for stage IVb esophageal squamous cell carcinoma: A propensity score matching analysis
    Chen, B.
    Chen, W.
    Yang, C.
    Cheng, Q.
    Cheng, X.
    Xi, M.
    Li, Q.
    Chen, B.
    ANNALS OF ONCOLOGY, 2023, 34 : S879 - S879
  • [28] Efficacy and safety of apatinib treatment for advanced esophageal squamous cell carcinoma
    Li, Jianqiang
    Wang, Lifen
    ONCOTARGETS AND THERAPY, 2017, 10 : 3965 - 3969
  • [29] Is chemoimmunotherapy a game changer in the treatment of locally advanced head and neck squamous cell carcinoma?
    Masuda, Muneyuki
    Nagata, Ryozaburo
    Hara, Hirotaka
    Kuroki, Keiji
    Sato, Kuniaki
    Rikimaru, Fumihide
    Toh, Satoshi
    Higaki, Yuichiro
    CLINICAL CASE REPORTS, 2021, 9 (09):
  • [30] Comparison of Efficacy and Safety of Combined Chemoimmunotherapy With or Without Radiation Therapy for Stage IVB Esophageal Squamous Cell Carcinoma: A Multicenter Propensity Score Matching Analysis
    Chen, Biqi
    Chen, Wenyan
    Cheng, Qi
    Zhang, Hao
    Wang, Bingyi
    Xu, Yujin
    Yang, Chen
    Cheng, Xingyuan
    Wang, Ruixi
    Wang, Sifen
    Cen, Peiying
    Wang, Lin
    Dragomir, Mihnea P.
    Zhu, Yujia
    Liu, Shiliang
    Xi, Mian
    Li, Qiaoqiao
    Chen, Baoqing
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (04): : 1084 - 1095
12345